Maiwald

Alexander Ortlieb, Moritz Kampmann, and Stephan Maidl of Maiwald highlight six EPO appeal decisions that map the absolute floor of what patent applications for AI inventions must disclose – and how spectacularly some applicants miss that mark

A single process patent and a well-executed intellectual property strategy can hold the key to unlocking long-term commercial success, says Christian Meyer of Maiwald, in an article co-written with Footprint Technologies

The handbook tackles the challenging task of making German life sciences patent law accessible to international practitioners. Xenia Boergen of Boergen Legal & Patents reviews an impressive undertaking by Marco Stief, Maximilian Haedicke, and Annelie Wünsche

The EPO’s Enlarged Board of Appeal has confirmed that interveners in European Patent Convention appeal proceedings remain dependent parties and cannot continue proceedings after the withdrawal of all appeals, reports Johannes Scholz of Maiwald

Kerstin Wolff of Maiwald explains how the EU’s provisional agreement on plants generated by new genomic techniques divides them into two categories, opening the market while preserving patent and regulatory oversight

Senior intellectual property practitioners from Maiwald discuss how innovators can secure robust patent protection for AI inventions amid evolving EPO practice and accelerating technological change